BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 32 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $722,000 | -32.3% | 550,000 | -45.0% | 0.00% | 0.0% |
| Q1 2020 | $1,066,000 | +373.8% | 1,000,000 | +400.0% | 0.00% | – |
| Q2 2019 | $225,000 | -0.9% | 200,000 | 0.0% | 0.00% | – |
| Q1 2019 | $227,000 | -59.0% | 200,000 | -60.0% | 0.00% | -100.0% |
| Q4 2018 | $554,000 | +515.6% | 500,000 | +566.7% | 0.00% | – |
| Q3 2018 | $90,000 | -56.3% | 75,000 | -57.1% | 0.00% | – |
| Q2 2018 | $206,000 | – | 175,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 6,195,000 | $9,377,000 | 2.84% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $10,750,000 | 1.09% |
| Man Investments (CH) AG | 1,100,000 | $1,482,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 22,554,000 | $30,444,000 | 0.47% |
| SSI INVESTMENT MANAGEMENT LLC | 3,124,000 | $4,202,000 | 0.45% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 20,000 | $22,373,000 | 0.42% |
| Calamos Advisors LLC | 35,219,000 | $47,628,000 | 0.33% |
| LINDEN ADVISORS LP | 2,500,000 | $3,370,000 | 0.23% |
| Calamos Wealth Management LLC | 513,000 | $694,000 | 0.17% |
| LOOMIS SAYLES & CO L P | 477,810 | $50,323,000 | 0.15% |